
Kidney Stones
Latest News
Latest Videos

Shorts



More News

Laser technology is expected to play a major role in the next wave of innovation.

Learn how suction has become central to contemporary ureteroscopic practice and how its integration is reshaping surgical decision-making, treatment algorithms, and the perceived role of percutaneous procedures.

Karen L. Stern, MD, and Naeem Bhojani, MD, FRCSC, outline the advantages of CVAC 2.0, particularly in cases involving larger stone burdens.

Experts compare and contrast direct in-scope suction with the flexible and navigable ureteric access sheath.

In this opening segment, the discussion focuses on the rapid evolution of kidney stone surgery and how suction has transitioned from an aspirational idea to a core component of modern ureteroscopy.

In September 2024, the FDA granted an Orphan Drug Designation and a Rare Pediatric Disease Designation to YOLT-203 for PH1.

"The more I use [SURE], the more applications I see with it," says Matthew A. Love, MD.

A recap of the FDA submissions and regulatory decisions in urology from October 2025.

Avvio Medical plans to submit a de novo application for clearance of the device in early 2026.

Amy E. Krambeck, MD, explained that active suction provided by FANS helps reduce intrarenal pressure by continuously removing irrigation fluid.

Krambeck highlights that FANS combine enhanced maneuverability and effective fragment evacuation, leading to higher stone clearance rates and improved procedural outcomes in endourology.

"Suctioning technology for mini-PCNL is an improvement on relying on passive outflow," says Mantu Gupta, MD.

In this episode, Gregory E. Tasian, MD, MSc, MSCE, Jonathan S. Ellison, MD, and patient partner Annabelle Pleskoff reflect on the origins, design, and key findings of the PKIDS trial.

We recap notable headlines from last month in the benign urology space.

Krambeck pointed to the growing importance of medical management in stone disease prevention.

Margaret A. Knoedler, MD, discusses her experience using the Reverse Deflection CVAC System.

Both the Dornier Hoover Flexible and Navigable Suction Ureteral Access Sheath and the Dornier Axis II Slim single-use ureteroscope are FDA-cleared.

The Focalist device obtained FDA clearance in the US in July 2025.

Two-year outcomes from the ASPIRE trial continued to show that the SURE procedure led to significantly reduced health care consumption events compared with ureteroscopy.

Kevin Koo, MD, MPH, discusses the implications of a digital stone measurement tool for clinical care.

Kevin Koo, MD, MPH, discusses a recent study on the utility of a digital stone measurement tool for ureteroscopy.

We recap notable headlines from last month in the benign urology space.

Joseph Song, MD, discusses his approach to patient selection for the SURE procedure, particularly in comparison to more invasive options such as PCNL.

The findings suggest that urolithiasis continues to pose a significant healthcare burden worldwide.

New findings from the PKIDS trial raise questions about the preference for ureteroscopy in clinical practice.













